Clinical Trial

A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes

Study acronym: ON LiMiT
Recruiting
View on ClinicalTrials.gov →
Summary
The overall aim of this study is to examine the feasibility of a 12-month, two-arm lifestyle intervention to induce and maintain remission of type 2 diabetes (T2D). The findings from the feasibility study will inform the recruitment, design and delivery of the interventions in a 5-arm, 24-month randomised controlled trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Trial Details
NCT Number NCT07262788
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: Aarhus University Hospital, Steno Diabetes Center Odense, University of Copenhagen, The Novo Nordisk Foundation Center for Basic Metabolic Research, Bispebjerg Hospital
Conditions Type 2 Diabetes
Enrollment 24 participants
Start Date 2025-09-30
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-03